Welcome to our dedicated page for Magellan Health news (Ticker: MGLN), a resource for investors and traders seeking the latest updates and insights on Magellan Health stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Magellan Health's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Magellan Health's position in the market.
Magellan Health, Inc. (MGLN) will release its Q3 2020 financial results on October 29, 2020, at 6:30 AM Eastern. Following this, a conference call is scheduled at 9:00 AM Eastern for management to discuss the results. Investors can participate by calling 877-269-7756 (Toll free) or 201-689-7817 (International) using confirmation number 13710919. A replay of the call will be available until November 29, 2020, with webcasts accessible for 30 days post-event.
Magellan focuses on managing complex areas of healthcare and serves a broad range of customers.